Document is current
Any future updates will be listed below
-
Authors
Patel, Maitray A. http://orcid.org/0000-0003-1141-8253
Knauer, Michael J. http://orcid.org/0000-0002-2240-4730
Nicholson, Michael
Daley, Mark http://orcid.org/0000-0002-6939-9772
Van Nynatten, Logan R.
Martin, Claudio http://orcid.org/0000-0003-3971-3166
Patterson, Eric K. http://orcid.org/0000-0003-3697-3042
Cepinskas, Gediminas http://orcid.org/0000-0002-0267-6659
Seney, Shannon L.
Dobretzberger, Verena
Miholits, Markus
Webb, Brian
Fraser, Douglas D. http://orcid.org/0000-0002-5635-3791
-
Funding
Funding for this research was provided by:
Academic Medical Organization of Southwestern Ontario
- License Information
-
More Information
Article History
Received: 8 July 2022
Accepted: 17 September 2022
First Online: 10 October 2022
Declarations
:
: This study was approved by the Western University, Human Research Ethics Board (HREB): Long-COVID outpatients (HREB# 120084, issued November 15, 2021); acutely ill COVID-19 inpatients (HREB #6970, renewed March 17, 2021) and volunteer healthy control subjects (HREB #16986E, renewed March 9, 2021).
: Not applicable.
: V.D., M.M. and B.W. are employees of Thermo Fisher Scientific Inc. who manufacture and distribute multiplex immunoassays as research use only reagents. The remaining authors have disclosed that they do not have any potential conflicts of interest.
